Dr. Kulke on Unanswered Questions Surrounding the Treatment of NETs

Matthew Kulke, MD
Published: Monday, Oct 13, 2014

Matthew Kulke, MD, director, Program in Neuroendocrine and Carcinoid Tumors, Dana-Farber Cancer Institute, chair, North American Neuroendocrine Tumor Society (NANETS), comments on some unanswered questions surrounding the treatment of neuroendocrine tumors (NETs).

It is encouraging that new treatments exist to help patients with NETs, Kulke says, but questions remain regarding their best use — the appropriate combination and sequence is likely different for every patient.

A larger question, Kulke says, concerns the underlying molecular drivers of NETs. This area is just beginning to be understood with the help of genomic and proteomic studies. As the growth of NETs is fully understood, researchers can be smarter about developing drugs.

<<< View more from NANETS

Matthew Kulke, MD, director, Program in Neuroendocrine and Carcinoid Tumors, Dana-Farber Cancer Institute, chair, North American Neuroendocrine Tumor Society (NANETS), comments on some unanswered questions surrounding the treatment of neuroendocrine tumors (NETs).

It is encouraging that new treatments exist to help patients with NETs, Kulke says, but questions remain regarding their best use — the appropriate combination and sequence is likely different for every patient.

A larger question, Kulke says, concerns the underlying molecular drivers of NETs. This area is just beginning to be understood with the help of genomic and proteomic studies. As the growth of NETs is fully understood, researchers can be smarter about developing drugs.

<<< View more from NANETS




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x